- Home
- ACIU vs EFSI Comparison
ACIU vs EFSI Comparison
Compare ACIU & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- EFSI
- Stock Information
- Founded
- ACIU 2003
- EFSI 1881
- Country
- ACIU Switzerland
- EFSI United States
- Employees
- ACIU N/A
- EFSI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- EFSI Major Banks
- Sector
- ACIU Health Care
- EFSI Finance
- Exchange
- ACIU Nasdaq
- EFSI Nasdaq
- Market Cap
- ACIU 189.1M
- EFSI 161.4M
- IPO Year
- ACIU 2016
- EFSI N/A
- Fundamental
- Price
- ACIU $2.02
- EFSI $30.78
- Analyst Decision
- ACIU Strong Buy
- EFSI Strong Buy
- Analyst Count
- ACIU 1
- EFSI 2
- Target Price
- ACIU $12.00
- EFSI $40.00
- AVG Volume (30 Days)
- ACIU 128.8K
- EFSI 55.2K
- Earning Date
- ACIU 08-05-2025
- EFSI 08-25-2025
- Dividend Yield
- ACIU N/A
- EFSI 4.03%
- EPS Growth
- ACIU N/A
- EFSI N/A
- EPS
- ACIU N/A
- EFSI 1.52
- Revenue
- ACIU $32,014,254.00
- EFSI $58,067,000.00
- Revenue This Year
- ACIU N/A
- EFSI $3.16
- Revenue Next Year
- ACIU $533.21
- EFSI $22.35
- P/E Ratio
- ACIU N/A
- EFSI $20.20
- Revenue Growth
- ACIU 91.20
- EFSI N/A
- 52 Week Low
- ACIU $1.43
- EFSI $28.70
- 52 Week High
- ACIU $4.26
- EFSI $36.93
- Technical
- Relative Strength Index (RSI)
- ACIU 57.93
- EFSI N/A
- Support Level
- ACIU $2.01
- EFSI N/A
- Resistance Level
- ACIU $2.19
- EFSI N/A
- Average True Range (ATR)
- ACIU 0.14
- EFSI 0.00
- MACD
- ACIU 0.00
- EFSI 0.00
- Stochastic Oscillator
- ACIU 60.75
- EFSI 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.